POPE LEO XIV TO UNDERGO LUNG SURGERY. (PHOTO).

Image
 POPE LEO XIV TO UNDERGO LUNG SURGERY Pope Leo XIV has announced that he will undergo surgery in the coming days to remove a lump on his lung, which was detected at a very early stage. During his weekly Angelus address in St Peter’s Square on Sunday, the 71-year-old pontiff told the crowd that a lung nodule had been discovered during recent medical checks and was highly localised. The statement by the Vatican press office adds that Doctors had recommended an operation to remove it, and that the procedure had already been planned.  It further confirms that his recovery was expected to take about one week. Born in Chicago, Leo became the first American pope in May 2025, following the death of his Argentine predecessor, Pope Francis, on 21 April 2025. He was elected on 8 May 2025 to lead the world’s 1.4 billion Catholics. Since assuming office, the former Robert Francis Prevost has gradually established his leadership style, speaking out on major global issues, including conflict...

NHIA UNVEILS NAFDAC LOGO FOR 33 MEDICAL PRODUCTS.(PHOTOS).



 

NHIA Unveils NAFDAC Logo For 33 Medical Products


National Health Insurance Authority (NHIA) has unveiled the logo the National Agency for Food and Drug Administration and Control (NAFDAC) approved for use on 33 locally manufactured medical products for the Authority.


The Director General of NHIA, Professor Mohammed Sambo unveiled the logo to newsmen in Abuja during a joint conference with NAFDAC.


Professor Sambo explained that the collaboration was to ensure that subscribers have access to affordable and quality drugs, adding that it would solve the problem of out-of-stock syndrome in the nation’s health facilities.


The NHIA DG further said the authority was working with relevant agencies in the production and distribution of the drug to secure its quality.


NAFDAC Director General, Professor Mojisola Adeyeye who assured Nigerians of the drugs, warned that the agency would sanction anyone selling them outside the designed health facilities.


‘’NAFDAC has in the past five years developed a GMP Roadmap which continuously assures that pharmaceutical manufacturers in Nigeria remain compliant with global best practices. The GMP roadmap was designed to guide and help local manufacturers upgrade their facilities and procedures in line with current good manufacturing practice requirements. This initiative has enabled the Agency establish a baseline for monitoring compliance,’’ she maintained.


Professor Adeyeye said the approved drugs are suitable for the treatment of malaria, upper respiratory tract infections, childhood illnesses, and drugs being used by pregnant women.


On October 4, the NHIA signed a memorandum of understanding with 12 pharmaceutical companies and eight drug management organisations to produce 33 medical products for health insurance subscribers.

More photos below. 




Comments

Popular posts from this blog

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.